Pricing Log in Create free account

Oramed Pharmaceuticals Inc. (ORMP) vs Sutro Biopharma, Inc. (STRO)

Oramed Pharmaceuticals Inc. and Sutro Biopharma, Inc. are both Biotechnology companies. Oramed Pharmaceuticals Inc. and Sutro Biopharma, Inc. are of similar size ($171.8M and $164.8M). Sutro Biopharma, Inc. has negative trailing earnings, so its P/E is not meaningful; Oramed Pharmaceuticals Inc. trades at 0.9×. Oramed Pharmaceuticals Inc. grew revenue faster over the last twelve months: 48.8% against −56.3%. Oramed Pharmaceuticals Inc. has the higher net margin (0.00% vs −395.3%) and the lower return on invested capital (−3.40% vs 0.00%). Across the 16 metrics below, Oramed Pharmaceuticals Inc. leads on 9 and Sutro Biopharma, Inc. on 7.

Valuation

Metric ORMP STRO Biotechnology median
P/E 0.93 n/m 10.26
P/S 40.01 3.34 9.18
P/B 0.51 n/m 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 0.03 0.65
EV/Sales 27.42 (0.08) 8.98
Earnings yield 107.91% (187.89%) (34.89%)
Free cash flow yield (3.24%) (95.31%) (24.52%)

Profitability

Metric ORMP STRO Biotechnology median
Gross margin 32.31% 100.00% 65.16%
Operating margin 0.00% (319.57%) 0.00%
Net margin 0.00% (395.25%) 0.00%
Free cash flow margin 0.00% (318.63%) 0.00%
Return on equity 73.90% 266.76% (50.12%)
Return on assets 65.52% (79.08%) (45.60%)
Return on invested capital (3.40%) 0.00% 0.00%

Growth

Metric ORMP STRO Biotechnology median
Revenue growth (TTM) 48.76% (56.25%) 6.26%
EPS growth (last fiscal year) 412.50% 24.02% 29.88%
Revenue growth, 5-year CAGR (5.85%) 19.12% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ORMP STRO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.98 3.32 4.89
Net debt to EBITDA 8.41 0.92 1.01

Dividend

Metric ORMP STRO Biotechnology median
Dividend yield 6.38% — 0.41%
Payout ratio 0.06 — —

Size

Metric ORMP STRO Biotechnology median
Market cap 171.80m 164.82m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack